Galapagos NV
GLPG
#4961
Rank
โ‚น177.10 B
Marketcap
โ‚น2,637
Share price
0.00%
Change (1 day)
5.91%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): -โ‚น37.14

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -โ‚น38.74. In 2024 the company made an earnings per share (EPS) of โ‚น110.84 a decrease over its 2023 EPS that were of โ‚น337.47.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น37.14
2024โ‚น110.84-67.16%
2023โ‚น337.47-199.64%
2022-โ‚น338.6899.03%
2021-โ‚น170.17-68.98%
2020-โ‚น548.60-298.06%
2019โ‚น276.99-554.64%
2018-โ‚น60.92-77.18%
2017-โ‚น267.01-326.21%
2016โ‚น118.04-134.19%
2015-โ‚น345.22-371.34%
2014โ‚น127.23-445.98%
2013-โ‚น36.7732.88%
2012-โ‚น27.67-82.07%
2011-โ‚น154.38-817.9%
2010โ‚น21.5012.73%
2009โ‚น19.08-120.79%
2008-โ‚น91.74-37.67%
2007-โ‚น147.1939.64%
2006-โ‚น105.4128.17%
2005-โ‚น82.246.25%
2004-โ‚น77.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น830.83-2,244.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น343.18-985.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น195.56-604.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น243.42-728.35%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น338.30-973.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น660.94-1,806.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น369.59-1,054.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-โ‚น58.01 49.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น130.29-436.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel